Image-based quantitative neuropathology used to stratify 84 donors and generate continuous disease pseudoprogression scores spanning the AD pathology spectrum.

Neuropathology Score: 0.500 Price: $0.50 Alzheimer's disease human Status: extracted

What This Experiment Tests

Neuropathology experiment designed to assess clinical efficacy targeting N/A in human. Primary outcome: Image-based quantitative neuropathology used to stratify 84 donors and generate continuous disease p

Description

Quantitative neuropathology imaging to establish disease progression timeline for downstream molecular profiling

TARGET GENE

N/A

MODEL SYSTEM

human

ESTIMATED COST

TIMELINE

0 months

PATHWAY

N/A

SOURCE

pmid_37292694

PRIMARY OUTCOME

Image-based quantitative neuropathology used to stratify 84 donors and generate continuous disease pseudoprogression scores spanning the AD pathology spectrum.

Scoring Dimensions

Related Hypotheses (1)

TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxicity in Alzheimer's Disease0.827

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.